Grants and Contributions:
Title:
Develop and execute the company’s revised strategic plan for the implementation of a unique harm and intervention reduction initiative
Agreement Number:
988555
Agreement Value:
$50,000.00
Agreement Date:
Apr 18, 2022 - Jan 24, 2023
Description:
This project is focused on further expansion the company’s suite of offerings to position it as a market leader in the delivery of services to enhance health and reduce dependence on pharmaceutical interventions. Specifically implementation of the Strategic Plan for the company’s innovative harm reduction program is to be undertaken as a result of this project.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Gimli, Manitoba, CA R0C 1B0
Reference Number:
172-2022-2023-Q1-988555
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
714721313
Recipient Type:
For-profit organization
Recipient's Operating Name:
Ekosi
Recipient's Legal Name:
Ekosi Health Centre Corp.
Federal Riding Name:
Selkirk--Interlake--Eastman
Federal Riding Number:
46010
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410